Acetylsalicylic acid Recruiting Phase 3 Trials for Mucocutaneous Lymph Node Syndrome Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04078568Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease